Capital Analysts LLC raised its position in shares of The Clorox Company (NYSE:CLX) by 39.8% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 710 shares of the company’s stock after buying an additional 202 shares during the period. Capital Analysts LLC’s holdings in The Clorox were worth $137,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in CLX. Bank of New York Mellon Corp raised its stake in shares of The Clorox by 4.8% in the first quarter. Bank of New York Mellon Corp now owns 1,551,035 shares of the company’s stock valued at $299,164,000 after acquiring an additional 70,987 shares in the last quarter. Norges Bank acquired a new stake in shares of The Clorox in the fourth quarter valued at $254,283,000. Stifel Financial Corp raised its stake in shares of The Clorox by 4.1% in the first quarter. Stifel Financial Corp now owns 1,133,754 shares of the company’s stock valued at $218,684,000 after acquiring an additional 44,189 shares in the last quarter. Price T Rowe Associates Inc. MD raised its stake in shares of The Clorox by 9.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 1,123,966 shares of the company’s stock valued at $216,791,000 after acquiring an additional 96,332 shares in the last quarter. Finally, Champlain Investment Partners LLC acquired a new stake in shares of The Clorox in the first quarter valued at $200,453,000. Institutional investors and hedge funds own 77.62% of the company’s stock.
Several analysts have recently issued reports on the company. DA Davidson reduced their price objective on The Clorox from $189.00 to $177.00 and set a “neutral” rating on the stock in a research note on Monday, May 3rd. Royal Bank of Canada restated a “neutral” rating on shares of The Clorox in a research note on Wednesday, May 5th. Deutsche Bank Aktiengesellschaft cut their price target on The Clorox from $195.00 to $186.00 and set a “hold” rating on the stock in a research note on Monday, May 3rd. Argus cut their price target on The Clorox from $230.00 to $206.00 and set a “buy” rating on the stock in a research note on Friday, May 21st. Finally, UBS Group initiated coverage on The Clorox in a research note on Wednesday, June 23rd. They issued a “sell” rating and a $166.00 price target on the stock. Four investment analysts have rated the stock with a sell rating, ten have issued a hold rating and four have assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average price target of $202.33.
The Clorox (NYSE:CLX) last announced its quarterly earnings data on Thursday, April 29th. The company reported $1.62 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.48 by $0.14. The Clorox had a return on equity of 104.74% and a net margin of 12.27%. The company had revenue of $1.78 billion for the quarter, compared to analyst estimates of $1.86 billion. During the same quarter in the previous year, the company earned $1.89 EPS. The firm’s revenue for the quarter was down .1% compared to the same quarter last year. On average, equities analysts predict that The Clorox Company will post 7.58 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 13th. Shareholders of record on Wednesday, July 28th will be issued a $1.16 dividend. This represents a $4.64 dividend on an annualized basis and a yield of 2.59%. The ex-dividend date is Tuesday, July 27th. This is a positive change from The Clorox’s previous quarterly dividend of $1.11. The Clorox’s payout ratio is currently 60.33%.
The Clorox Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Scentiva, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; professional cleaning, disinfecting, and food service products under the CloroxPro, Clorox Healthcare, and Clorox Total 360 brands; professional food service products under the Hidden Valley brand; and vitamins, minerals, and supplement products under the RenewLife, Rainbow Light, Natural Vitality, NeoCell, and Stop Aging Now brands.
Recommended Story: What are high-yield dividend stocks?
Receive News & Ratings for The Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Clorox and related companies with MarketBeat.com's FREE daily email newsletter.